ArticleCancer research communications2026

A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.

Barak Talmor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.